Another all time low ... how could Liminal management screw this company up any more? Of course, they are still getting handsome salaries for their value.
The press releases and actions certainly seem to have been timed and complete on purpose hiding value of 4050 / Fezagrapras and just fire selling Ryplazim. Thomvest just want this situation to end and get out selling 4050 privately to whoever they can who were at the table in 2018.
Follow the IP!